Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Phosphorus, |
RCV000577991 | SCV000679821 | uncertain significance | Arrhythmogenic right ventricular dysplasia 2 | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578067 | SCV000679822 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000577933 | SCV000679823 | uncertain significance | Left ventricular noncompaction | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000578067 | SCV001497317 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 1 | 2023-03-08 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with RYR2-related conditions. This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 4471 of the RYR2 protein (p.Gly4471Ala). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 488158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |